UI Pharmaceuticals has mobilized its unique resources to support novel treatments for patients suffering COVID-19 infections. UI Pharmaceuticals has prioritized and channeled our expertise towards supporting three novel programs using different approaches to treating complications associated with COVID-19 infections. Through the flexibility of our facility and dedication of our staff, we accelerated production scheduling to within six-weeks of proposal acceptance by our clients.  We are proud to be involved in the development of potential treatments for COVID-19 infections and look forward to supporting similar projects in the future, as well as providing the quality and customer service our clients have come to expect from UI Pharmaceuticals.